Rise Therapeutics
Rockville
About Rise Therapeutics
Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. Rise leverages its target discovery expertise to understand microbiome gut biology as it relates to regulation of immune function.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Grant (Sep 2025)
- Website: risetherapeutics.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rise-therapeutics-144833 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.